Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Cancer Chemotherapy and Pharmacology|June 15, 2000
Pharmacokinetics of intraperitoneal hyperthermic perfusion with mitoxantrone in ovarian cancerM O Nicoletto, R Padrini, F Galeotti, et al.
Clinical Pharmacology and Therapeutics|February 16, 2007
A PK-PD model for predicting the impact of age, CYP2C9, and VKORC1 genotype on individualization of warfarin therapyA-K Hamberg, M-L Dahl, M Barban, et al.
European Journal of Clinical Pharmacology|January 1, 1993
Dose-dependent absorption and elimination of gamma-hydroxybutyric acid in healthy volunteersP Palatini, L Tedeschi, G Frison, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Continuous mitoxantrone infusion in pretreated epithelial ovarian cancerM O Nicoletto, R Padrini, H Koussis, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Phase I-II intraperitoneal mitoxantrone in advanced pretreated ovarian cancerM O Nicoletto, R Padrini, E Ferrazzi, et al.
European Journal of Clinical Pharmacology|March 9, 2016
Donepezil plasma concentrations, CYP2D6 and CYP3A4 phenotypes, and cognitive outcome in Alzheimer's diseaseA Coin, M V Pamio, C Alexopoulos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 14, 2006
Pharmacokinetic and demographic markers of 5-fluorouracil toxicity in 181 patients on adjuvant therapy for colorectal cancerM Gusella, G Crepaldi, C Barile, et al.
Pageof 7